RSS Subscribe to our Nanotechnology Business News feed

AMAG Pharmaceuticals, Inc. Announces Eight Abstracts on Ferumoxytol to Be Presented at Upcoming American Society of Nephrology Meeting

Pharmaceuticals, Inc., a biopharmaceutical company that utilizes its proprietary nanoparticle technology for the development and commercialization of therapeutic iron compounds to treat anemia, today announced that eight abstracts on ferumoxtytol, its lead product candidate, have been accepted for presentation at the American Society of Nephrology meeting.

Oct 10th, 2007

Read more

Octillion Increases Research Staff for the Development of NanoPower Windows

In response to recent technological breakthroughs and a doubling of research and development funding by Octillion Corp, the Company is pleased to announce that, in addition to recently added managerial and support staff, it has increased its research staff to four, with plans to further boost research personnel, contingent upon ongoing results from the development of the Company's first-of-its-kind transparent glass window capable of generating electricity.

Oct 9th, 2007

Read more